SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001477932-24-008337 from INNOVATIVE MEDTECH, INC. (IMTH) (CIK 0001331612)

INNOVATIVE MEDTECH, INC. (IMTH) (CIK 0001331612)
Date: Dec. 27, 2024 · CIK: 0001331612 · Accession: 0001477932-24-008337

AI Filing Summary & Sentiment

File numbers found in text: 024-12549

Date
December 27, 2024
Author
Not clearly detected
Form
CORRESP
Company
INNOVATIVE MEDTECH, INC. (IMTH) (CIK 0001331612)

Letter

imth_corresp.htm

INNOVATIVE MEDTECH, INC.

December 27, 2024

Via EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, DC 20549

Re: Innovative Medtech, Inc.

Offering Statement on Form 1-A

Filed December 20, 2024

File No. 024-12549

Ladies and Gentlemen:

On behalf of Innovative MedTech, Inc. (the “Company”), I hereby request qualification of the Company’s above-referenced offering statement (the “Offering Statement”) at 4:00 p.m. Eastern Time, on December 31, 2024, or as soon thereafter as is practicable.

The Company confirms that there are no participants in the offering contemplated by the Offering Statement that are required to clear their compensation arrangements with FINRA.

Very truly yours,
INNOVATIVE MEDTECH, INC.

Show Raw Text
CORRESP
1
filename1.htm

imth_corresp.htm

 INNOVATIVE MEDTECH, INC.

 December 27, 2024

 Via EDGAR

 United States Securities and Exchange Commission

 Division of Corporation Finance

 Office of Industrial Applications and Services

 100 F Street, N.E.

 Washington, DC 20549

 Re: Innovative Medtech, Inc.

 Offering Statement on Form 1-A

 Filed December 20, 2024

 File No. 024-12549

 Ladies and Gentlemen:

 On behalf of Innovative MedTech, Inc. (the “Company”), I hereby request qualification of the Company’s above-referenced offering statement (the “Offering Statement”) at 4:00 p.m. Eastern Time, on December 31, 2024, or as soon thereafter as is practicable.

 The Company confirms that there are no participants in the offering contemplated by the Offering Statement that are required to clear their compensation arrangements with FINRA.

 Very truly yours,

 INNOVATIVE MEDTECH, INC.

 /s/ Michael Friedman

 Michael Friedman

 Chief Executive Officer